Willem van Oeveren

5.7k total citations
101 papers, 4.3k citations indexed

About

Willem van Oeveren is a scholar working on Surgery, Biomedical Engineering and Biochemistry. According to data from OpenAlex, Willem van Oeveren has authored 101 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Surgery, 41 papers in Biomedical Engineering and 30 papers in Biochemistry. Recurrent topics in Willem van Oeveren's work include Cardiac and Coronary Surgery Techniques (62 papers), Mechanical Circulatory Support Devices (37 papers) and Blood transfusion and management (30 papers). Willem van Oeveren is often cited by papers focused on Cardiac and Coronary Surgery Techniques (62 papers), Mechanical Circulatory Support Devices (37 papers) and Blood transfusion and management (30 papers). Willem van Oeveren collaborates with scholars based in Netherlands, United States and Germany. Willem van Oeveren's co-authors include Charles R.H. Wildevuur, Yongquan Gu, J. de Haan, L. Eijsman, Piet W. Boonstra, K. J. Roozendaal, Gerhard Rakhorst, Piet W. Boonstra, Massimo A. Mariani and Nicolaas J. G. Jansen and has published in prestigious journals such as Blood, Diabetes Care and PEDIATRICS.

In The Last Decade

Willem van Oeveren

100 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willem van Oeveren Netherlands 34 2.8k 1.4k 1.3k 1.0k 678 101 4.3k
Charles R.H. Wildevuur Netherlands 34 2.7k 0.9× 877 0.6× 1.2k 0.9× 707 0.7× 338 0.5× 85 3.9k
L. Eijsman Netherlands 29 1.6k 0.6× 518 0.4× 1.3k 1.0× 695 0.7× 395 0.6× 63 3.2k
T. Brett Reece United States 35 2.1k 0.7× 538 0.4× 2.0k 1.5× 664 0.7× 547 0.8× 181 5.2k
Silvana Marasco Australia 37 3.4k 1.2× 1.5k 1.1× 1.2k 0.9× 341 0.3× 349 0.5× 199 5.2k
Andreas Koster Germany 42 3.9k 1.4× 1.2k 0.9× 2.2k 1.7× 899 0.9× 813 1.2× 198 5.6k
Tatu Juvonen Finland 43 2.7k 1.0× 358 0.3× 2.5k 1.9× 172 0.2× 446 0.7× 230 6.5k
Alexander B.A. Vonk Netherlands 26 1.0k 0.4× 262 0.2× 968 0.7× 566 0.6× 664 1.0× 75 2.4k
Wim van Oeveren Netherlands 33 1.1k 0.4× 530 0.4× 579 0.4× 122 0.1× 218 0.3× 83 2.8k
Guido A. Wanner Switzerland 38 2.0k 0.7× 589 0.4× 148 0.1× 183 0.2× 504 0.7× 98 4.1k
Gideon Uretzky Israel 29 1.5k 0.5× 333 0.2× 1.1k 0.9× 144 0.1× 196 0.3× 145 2.6k

Countries citing papers authored by Willem van Oeveren

Since Specialization
Citations

This map shows the geographic impact of Willem van Oeveren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem van Oeveren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem van Oeveren more than expected).

Fields of papers citing papers by Willem van Oeveren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem van Oeveren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem van Oeveren. The network helps show where Willem van Oeveren may publish in the future.

Co-authorship network of co-authors of Willem van Oeveren

This figure shows the co-authorship network connecting the top 25 collaborators of Willem van Oeveren. A scholar is included among the top collaborators of Willem van Oeveren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem van Oeveren. Willem van Oeveren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boertien, Wendy E., Esther Meijer, Paul E. de Jong, et al.. (2015). Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. American Journal of Kidney Diseases. 65(6). 833–841. 66 indexed citations
2.
Gerritsen, Karin G. F., Jan Willem Leeuwis, Maarten P. Koeners, et al.. (2015). Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction. Journal of Diabetes Research. 2015. 1–11. 20 indexed citations
4.
Jansen, Piet, Willem van Oeveren, Antoine Capel, & A Carpentier. (2012). In vitro haemocompatibility of a novel bioprosthetic total artificial heart. European Journal of Cardio-Thoracic Surgery. 41(6). e166–e172. 33 indexed citations
5.
Henkelman, Sandra, Johan W.M. Lagerberg, Reindert Graaff, Gerhard Rakhorst, & Willem van Oeveren. (2010). The effects of cryopreservation on red blood cell rheologic properties. Transfusion. 50(11). 2393–2401. 26 indexed citations
6.
7.
Vermeijden, Wytze, et al.. (2008). Do repeated runs of a cell saver device increase the pro-inflammatory properties of washed blood?☆☆☆☆☆☆. European Journal of Cardio-Thoracic Surgery. 34(2). 350–353. 7 indexed citations
8.
Oeveren, Willem van, et al.. (2006). Adhesion of thrombotic components to the surface of a clinically used oxygenator is not affected by Trillium coating. Perfusion. 21(3). 165–172. 6 indexed citations
9.
Vries, Adrianus J. de, et al.. (2006). Clinical Efficacy and Biocompatibility of Three Different Leukocyte and Fat Removal Filters During Cardiac Surgery. Artificial Organs. 30(6). 452–457. 10 indexed citations
10.
Graaff, R., Yongquan Gu, P.W. Boonstra, Willem van Oeveren, & Gerhard Rakhorst. (2004). Analysis of Red Blood Cell Aggregation in Cardio-Pulmonary Bypass (CPB) Surgery. The International Journal of Artificial Organs. 27(6). 488–494. 4 indexed citations
11.
Huet, R, et al.. (2000). A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 47(12). 1207–1215. 126 indexed citations
12.
Gu, Yongquan, et al.. (1999). Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfusion Science. 20(3). 151–165. 21 indexed citations
13.
Gu, Yongquan, Massimo A. Mariani, Willem van Oeveren, Jan G. Grandjean, & Piet W. Boonstra. (1998). Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery. 65(2). 420–424. 133 indexed citations
14.
Buikema, Hendrik, et al.. (1998). The use of the gastroepiploic artery for peripheral revascularisation. A study in pigs. European Journal of Vascular and Endovascular Surgery. 15(4). 320–326. 3 indexed citations
15.
Haan, J. de, J. P. A. M. Schönberger, J. de Haan, Willem van Oeveren, & A Eijgelaar. (1993). Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 106(6). 1017–1023. 50 indexed citations
17.
Eijsman, L., et al.. (1991). Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. The Annals of Thoracic Surgery. 51(6). 936–941. 82 indexed citations
18.
Oeveren, Willem van, Heleen M. Oudemans–van Straaten, C. P. Stoutenbeek, et al.. (1991). Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 102(4). 515–525. 164 indexed citations
19.
Oeveren, Willem van, et al.. (1990). Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 99(5). 788–797. 295 indexed citations
20.
Oeveren, Willem van. (1988). Alterations in host defense mechanisms during cardiopulmonary bypass. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026